2-methyl-2-(3-methylbenzoylamino)propionic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-methyl-2-(3-methylbenzoylamino)propionic acid
• 英文别名: 2-Methyl-2-[(3-methylbenzoyl)amino]propanoic acid
• 化学式: C₁₂H₁₅NO₃
• 分子量: 221.256
• InChiKey: AICOUPASRRYRIH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-methyl-2-(3-methylbenzoylamino)propionic acid 在 copper dichloride 作用下， 以 二甲基亚砜 为溶剂， 反应 11.0h， 以86%的产率得到间甲苯乙酰胺
  参考文献：
  名称：

  Cu(Ⅱ)-促进N-苯甲酰氨基酸氧化CN键裂解为伯芳基酰胺

  摘要：

  开发了一种用于 CuCl2 促进的 N-苯甲酰基氨基酸氧化 CN 键裂解的新方案。这是使用可接近的氨基酸作为氨合成等价物通过 CuCl2 促进的氧化 CN 键裂解反应合成伯芳基酰胺的第一个例子。本协议显示出优异的官能团耐受性, 并提供了一种替代方法, 以 84-96% 的产率合成伯芳基酰胺。

  DOI：

  10.24820/ark.5550190.p009.726
• 作为产物：
  描述：

  2-甲基丙氨酸 、 间甲基苯甲酰氯 在 sodium hydroxide 作用下， 生成 2-methyl-2-(3-methylbenzoylamino)propionic acid
  参考文献：
  名称：

  Cu(Ⅱ)-促进N-苯甲酰氨基酸氧化CN键裂解为伯芳基酰胺

  摘要：

  开发了一种用于 CuCl2 促进的 N-苯甲酰基氨基酸氧化 CN 键裂解的新方案。这是使用可接近的氨基酸作为氨合成等价物通过 CuCl2 促进的氧化 CN 键裂解反应合成伯芳基酰胺的第一个例子。本协议显示出优异的官能团耐受性, 并提供了一种替代方法, 以 84-96% 的产率合成伯芳基酰胺。

  DOI：

  10.24820/ark.5550190.p009.726

文献信息

• Palladium-Catalyzed Ortho-Alkoxylation of <i>N</i>-Benzoyl α-Amino Acid Derivatives at Room Temperature
  作者：Shuangjie Li、Wei Zhu、Feng Gao、Chunpu Li、Jiang Wang、Hong Liu

  DOI：10.1021/acs.joc.6b02257

  日期：2017.1.6

  An efficient palladium-catalyzed ortho-alkoxylation of N-benzoyl α-amino acid derivatives at room temperature has been explored. This novel transformation, using amino acids as directing groups, Pd(OAc)2 as catalyst, alcohols as the alkoxylation reagents, and PhI(OAc)2 as the oxidant, showed wide generality, good functional tolerance, and high monoselectivity and regioselectivity.

  已经探索了在室温下钯的有效催化N-苯甲酰基α-氨基酸衍生物的邻烷氧基化。这种新颖的转化，以氨基酸为导向基团，以Pd（OAc）2为催化剂，以醇为烷氧基化试剂，以PhI（OAc）2为氧化剂，显示出广泛的通用性，良好的功能耐受性以及高单选择性和区域选择性。
• Ni(<scp>ii</scp>)-catalyzed mono-selective <i>ortho</i>-arylation of unactivated aryl C–H bonds utilizing amino acids as a directing group
  作者：Zhanqing Cong、Feng Gao、Hong Liu

  DOI：10.1039/c9ra00749k

  日期：——

  The nickel(II)-catalyzed ortho-arylation of unactivated C–H bonds utilizing amino acids as directing groups with aryl iodides or bromides as coupling electrophiles is described. This protocol features excellent mono-selectivity, good regioselectivity, and wide functional group tolerance. Additionally, the obtained products bearing a biaryl motif and an amino acid represent bioactive molecules with

  描述了镍 ( II ) 催化的未活化 C-H 键的邻位芳基化，利用氨基酸作为导向基团，芳基碘化物或溴化物作为偶联亲电体。该协议具有优异的单选择性、良好的区域选择性和广泛的官能团耐受性。此外，获得的带有联芳基基序和氨基酸的产物代表了具有广泛生物活性的生物活性分子。
• Arylalkylamine Compound and Process for Preparing the Same
  申请人：Miyazaki Hiroshi

  公开号：US20070225296A1

  公开（公告）日：2007-09-27

  The present invention relates to an arylalkylamine compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, a process for preparing the same, and use of the above-mentioned compound as an activating compound (CaSR agonist) of a Ca sensing receptor, a pharmaceutical composition containing the above-mentioned compound as an effective ingredient, etc. The symbols in the formula represent the following meanings: Ar: optionally substituted aryl or optionally substituted heteroaryl here, the cyclic portion of the heteroaryl is bicyclic heterocyclic ring in which 5- to 6-membered monocyclic heterocyclic ring containing 1 or 2 hetero atom(s) and benzene ring are fused; R 1 : a group selected from the group consisting of optionally substituted cyclic hydrocarbon group, and optionally substituted heterocyclic group; n: an integer of 1 to 3; X: single bonding arm, —CH 2 —, —CO—, —(CH 2 ) m —CO—, —CH(R 2 )—CO—, —(CH 2 ) p —Y—(C(R 3 )(R 4 )) q —CO—, —NH—CO— or —N(R 5 )—CO—; in the above-mentioned respective definitions of the X, the bonding arm described at the left end represents a bond with R 1 ; m is an integer of 1 to 3; p is an integer of 0 to 2; q is an integer of 0 to 2; Y: —O— or —SO 2 —; R 2 : phenyl or lower alkyl; R 3 , R 4 : each independently represents hydrogen atom or lower alkyl; R 5 : lower alkyl; provided that the ring portion of the group represented by R 1 is neither naphthylidine nor partially saturated group thereof, and, when X is —CH 2 — or —CO—, R 1 is not naphthyl.

  本发明涉及一种由以下公式[I]表示的芳基烷基胺化合物或其药学上可接受的盐，其制备方法，以及上述化合物作为钙感受受体的激活化合物（CaSR激动剂），以及含有上述化合物作为有效成分的制药组合物等的用途。公式中的符号表示以下含义：Ar：此处为可选取代的芳基或可选取代的杂环芳基，其中杂环的环部分是一个含有1或2个杂原子的5-至6元单环杂环，与苯环融合；R1：选自可选取代的环烃基团和可选取代的杂环基团的群；n：1至3的整数；X：单键臂、—CH2—、—CO—、—（CH2）m—CO—、—CH（R2）—CO—、—（CH2）p—Y—（C（R3）（R4））q—CO—、—NH—CO—或—N（R5）—CO—；在上述各定义的X中，左端所描述的键臂表示与R1的键；m为1至3的整数；p为0至2的整数；q为0至2的整数；Y：—O—或—SO2—；R2：苯基或低碳烷基；R3、R4：各自独立地表示氢原子或低碳烷基；R5：低碳烷基；前提是由R1表示的基团的环部分既不是萘亚甲基也不是其部分饱和基团，且当X为—CH2—或—CO—时，R1不是萘基。
• ARYLALKYLAMINE COMPOUND AND PROCESS FOR PREPARING THE SAME
  申请人：MIYAZAKI Hiroshi

  公开号：US20100249049A1

  公开（公告）日：2010-09-30

  The present invention relates to an arylalkylamine compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, a process for preparing the same, and use of the above-mentioned compound as an activating compound (CaSR agonist) of a Ca sensing receptor, a pharmaceutical composition containing the above-mentioned compound as an effective ingredient, etc. The symbols in the formula represent the following meanings: Ar: optionally substituted aryl or optionally substituted heteroaryl here, the cyclic portion of the heteroaryl is bicyclic heterocyclic ring in which 5- to 6-membered monocyclic heterocyclic ring containing 1 or 2 hetero atom(s) and benzene ring are fused; R 1 : a group selected from the group consisting of optionally substituted cyclic hydrocarbon group, and optionally substituted heterocyclic group; n: an integer of 1 to 3; X: single bonding arm, —CH 2 —, —CO—, —(CH 2 ) m —CO—, —CH(R 2 )—CO—, —(CH 2 ) p —Y—(C(R 3 )(R 4 )) q —CO—, —NH—CO— or —N(R 5 )—CO—; in the above-mentioned respective definitions of the X, the bonding arm described at the left end represents a bond with R 1 ; m is an integer of 1 to 3; p is an integer of 0 to 2; q is an integer of 0 to 2; Y: —O— or —SO 2 —; R 2 : phenyl or lower alkyl; R 3 , R 4 : each independently represents hydrogen atom or lower alkyl; R 5 : lower alkyl; provided that the ring portion of the group represented by R 1 is neither naphthylidine nor partially saturated group thereof, and, when X is —CH 2 — or —CO—, R 1 is not naphthyl.

  本发明涉及一种由下式[I]表示的芳基烷基胺化合物或其药学上可接受的盐，制备该化合物的方法，以及上述化合物作为钙感受受体（CaSR激动剂）的激活化合物、包含上述化合物作为有效成分的药物组合物等的用途。式中符号表示以下含义：Ar：可选取的取代芳基或可选取的取代杂环芳基，在此，所述杂环的环状部分是由1或2个杂原子的5-6元单环杂环与苯环融合而成的双环杂环；R1：选自可选取的取代环烃基团和可选取的取代杂环基团的群；n：为1至3的整数；X：单键连接臂，-CH2-，-CO-，-(CH2)m-CO-，-CH(R2)-CO-，-(CH2)p-Y-(C(R3)(R4))q-CO-，-NH-CO-或-N(R5)-CO-；在上述X的各自定义中，左端所述连接臂表示与R1的键合；m为1至3的整数；p为0至2的整数；q为0至2的整数；Y：-O-或-SO2-；R2：苯基或低碳烷基；R3，R4：各自独立地表示氢原子或低碳烷基；R5：低碳烷基；所述R1表示的基的环部分既不是萘亚甲基基团，也不是其部分饱和基团，当X为-CH2-或-CO-时，R1不是萘基。
• Composition containing a penem or carbapenem antibiotic
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0226304B1

  公开（公告）日：1991-08-28